SHIVALI KANAL: Open Payments
NPI 1861009482 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$532 in 18 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $91 · 2025 $532
Food & beverage: $532
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $154 |
| Janssen Biotech, Inc. | 1 | $107 |
| Regeneron Healthcare Solutions, Inc. | 4 | $105 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Stryker Corporation | 1 | $34 |
| ABBVIE INC. | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $16 |
Products named: DUPIXENT, RYBREVANT, NUCALA, XPRESS LOPROFILE, UBRELVY, KEYTRUDA, XOLAIR, NEFFY.
Industry payments across KY — which companies pay providers there.
